ArticleThe World Allergy Organization journal2026

Early control or gradual relief? Gender-specific real-world insights into omalizumab response in chronic spontaneous urticaria patients.

Sarah Preis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.